Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis (OPTIMIZE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Seattle Children's Hospital
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Bonnie Ramsey, Seattle Children's Hospital
ClinicalTrials.gov Identifier:
NCT02054156
First received: February 1, 2014
Last updated: May 9, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: February 2018 (Final data collection date for primary outcome measure)